| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/12/2008 | CA2131729C Helicobacter pylori proteins useful for vaccines and diagnostics |
| 02/12/2008 | CA2131153C Peptides stimulating cytotoxic lymphocytes response to hiv-i gp 160 |
| 02/12/2008 | CA2116500C Canine coronavirus vaccine from feline enteric coronavirus |
| 02/07/2008 | WO2008016984A2 Polysaccharide vaccine and uses thereof |
| 02/07/2008 | WO2008016976A2 Vaccines and methods for controlling adiposity |
| 02/07/2008 | WO2008016883A2 Inhibitors of plasma kallikrein |
| 02/07/2008 | WO2008016655A2 Method of administration of an hiv immunogenic composition |
| 02/07/2008 | WO2008016594A1 Picornavirus and uses thereof |
| 02/07/2008 | WO2008016141A1 Kif-derived peptide capable of binding to hla-a24 molecule |
| 02/07/2008 | WO2008015480A2 Composition and method for modulating an immune response |
| 02/07/2008 | WO2008015309A1 Dendrimeric peptide construct for the prevention of foot-and-mouth disease in animals |
| 02/07/2008 | WO2008015267A1 A method for the in vitro screening of anti-cancer compounds that inhibits sk3 activity, and said anti-cancer compounds |
| 02/07/2008 | WO2008014733A1 Medicament for lct poisoning |
| 02/07/2008 | WO2008014583A1 Cancerous disease modifying antibodies |
| 02/07/2008 | WO2008001108A3 Silicon adjuvant |
| 02/07/2008 | WO2007149809A3 Tacrolimus standard and methods of using same |
| 02/07/2008 | WO2007135546A3 TREATMENT OF CANCER WITH ANTI-IL-1α ANTIBODIES |
| 02/07/2008 | WO2007134350A8 Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases |
| 02/07/2008 | WO2007132178A3 Combination therapy product and uses thereof |
| 02/07/2008 | WO2007127317A3 Humanized c-kit antibody |
| 02/07/2008 | WO2007113633A3 Immunogenic compositions comprising cat allergen fel dl |
| 02/07/2008 | WO2007059360A3 Oral use of specific antibodies for intestinal health |
| 02/07/2008 | US20080033458 Multi-actuating trigger anchor delivery system |
| 02/07/2008 | US20080033157 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 02/07/2008 | US20080032388 Live Genetically Attenuated Malaria Vaccine |
| 02/07/2008 | US20080032384 Pharmaceutical Preparation Containing Bacterial Cell Wall Skeleton |
| 02/07/2008 | US20080032342 Chimeric immunogens |
| 02/07/2008 | US20080032336 Chemokine receptor materials and methods |
| 02/07/2008 | US20080031936 Immunostimulatory nucleic acid molecules |
| 02/07/2008 | US20080031903 Method of treating ocular infections |
| 02/07/2008 | US20080031899 Nanoparticles for immunotherapy |
| 02/07/2008 | US20080031898 Compositions and methods to increase the effect of a neurotoxin treatment |
| 02/07/2008 | US20080031897 Prevention of allergy in children |
| 02/07/2008 | US20080031896 Hydrophilic eimeria polypeptide; genetic engineering; vaccine for the protection of poultry against Eimeria infection |
| 02/07/2008 | US20080031895 Influenza virus-like particle (VLP) compositions |
| 02/07/2008 | US20080031890 Method of inducing neutralizing antibodies to human immunodeficiency virus |
| 02/07/2008 | US20080031889 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| 02/07/2008 | US20080031888 Tumor antigens |
| 02/07/2008 | US20080031887 Conjugates for inducing targeted immune responses and methods of making and using same |
| 02/07/2008 | US20080031886 Viruses for the treatment of cellular proliferative disorders |
| 02/07/2008 | US20080031885 Use of Goat Serum for Veterinary Treatment |
| 02/07/2008 | US20080031884 Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases |
| 02/07/2008 | US20080031883 Condition-dependent, multiple target delivery system |
| 02/07/2008 | US20080031882 Methods of modulating IL-22 and IL-17 |
| 02/07/2008 | US20080031881 Medicament for treating cancer |
| 02/07/2008 | US20080031880 Use of ErbB receptor ligands in treating diabetes |
| 02/07/2008 | US20080031879 Wound healing agents; antiscarring; regeneration: antifibrotic agents: treatment of keloids or hypertrophic scars |
| 02/07/2008 | US20080031878 Polypeptides for the Diagnosis and Therapy of Leishamaniasis |
| 02/07/2008 | US20080031877 Purification of bacterial antigens |
| 02/07/2008 | US20080031876 Use preventing transplant rejection, treating autoimmune diseases, and in leukocyte typing and FAC sorting; CD28/CTLA4Ig fusion proteins |
| 02/07/2008 | US20080031875 Treatment method |
| 02/07/2008 | US20080031874 Treatment of endotoxemia using endotoxin neutralizing agents |
| 02/07/2008 | US20080031873 Humanized monoclonal antibody 31.1 as an anticancer agent |
| 02/07/2008 | US20080031872 HIV immunogenic composition and method of administration |
| 02/07/2008 | US20080031871 Memory and learning impairments associated with disruption of Ephrin receptor A6 (EphA6) gene |
| 02/07/2008 | US20080031870 Method of proliferation in neurogenic regions |
| 02/07/2008 | US20080031849 Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors |
| 02/07/2008 | US20080029083 Ejection liquid and ejection method |
| 02/07/2008 | DE102006035618A1 New nucleic acid useful as immuno-stimulating adjuvant for manufacture of a composition for treatment of cancer diseases e.g. colon carcinomas and infectious diseases e.g. influenza and malaria |
| 02/07/2008 | CA2659742A1 Method of administration of an hiv immunogenic composition |
| 02/07/2008 | CA2659684A1 Medicament for lct poisoning |
| 02/07/2008 | CA2659264A1 Vaccines and methods for controlling adiposity |
| 02/07/2008 | CA2658504A1 Cancerous disease modifying antibodies |
| 02/07/2008 | CA2656887A1 Antitumor combinations containing taxane derivatives |
| 02/06/2008 | EP1884774A1 A method for the in vitro screening of anti-cancer compounds that inhibits SK3 activity, and said anti-cancer compounds |
| 02/06/2008 | EP1884524A2 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 02/06/2008 | EP1884247A2 Gastrin compositions and formulations, and methods of use and preparation |
| 02/06/2008 | EP1883708A1 Genemap of the human genes associated with crohn's disease |
| 02/06/2008 | EP1883701A2 Expression of viral proteins in plants |
| 02/06/2008 | EP1883653A2 Recombinant method for the production of a monoclonal antibody to cd52 for the treatment of chronic lymphocytic leukemia |
| 02/06/2008 | EP1883424A2 Methods for treating fibrotic conditions |
| 02/06/2008 | EP1883423A2 Compositions and methods for modulating cells via cd14 and toll-like receptor 4 signaling pathway |
| 02/06/2008 | EP1883422A2 Tcr-independent activation of t cells |
| 02/06/2008 | EP1883421A2 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| 02/06/2008 | EP1883420A2 Compositions and methods for diagnosing, predicting therapeutic response of, and monitoring autoimmune disease |
| 02/06/2008 | EP1883410A2 Antibody or antibody fragment coupled with an immunogenic agent |
| 02/06/2008 | EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/06/2008 | CN101120256A Use of NT-proANP/NT-proBNP ratio for diagnosing cardiac dysfunctions |
| 02/06/2008 | CN101120101A Apparatus and method for transdermal delivery of multiple vaccines |
| 02/06/2008 | CN101120088A Pharmaceutical composition comprising a bacterial cell displaying a heterologous proteinaceous compound |
| 02/06/2008 | CN101120087A Anti-il-12 antibodies, epitopes, compositions, methods and uses |
| 02/06/2008 | CN101120020A Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy |
| 02/06/2008 | CN101120018A Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype |
| 02/06/2008 | CN101120016A Adamts-7 as a biomarker for cancers of epithelial origin |
| 02/06/2008 | CN101120015A Interleukin-15 antagonist peptide |
| 02/06/2008 | CN101120014A Modulation of ovulation |
| 02/06/2008 | CN101120013A Novel efficient production process for capsular polysaccharides of pathogenic grampositive bacteria by heterologous expression and secretion of complex polysaccharides in non-pathogenic, non-invasive |
| 02/06/2008 | CN101119746A Agent for stimulating the production of a blood coagulation factor VIII |
| 02/06/2008 | CN101119745A Lectin compositions and methods for modulating an immune response to an antigen |
| 02/06/2008 | CN101119744A Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 02/06/2008 | CN101117644A Diagnostics and therapeutics for glaucoma |
| 02/06/2008 | CN101117627A Pig epidemic diarrhea virus attenuated vaccine strain and uses thereof |
| 02/06/2008 | CN101116749A Swine fever replicon carrier vaccines, the method for preparing the same and application thereof |
| 02/06/2008 | CN101116748A Adriablastina antineoplastic medicine and gland correlated virus composite preparations and uses thereof |
| 02/06/2008 | CN101116747A Cytosine arabinoside and gland correlated virus composite preparations and uses thereof |
| 02/06/2008 | CN101116746A Prevention and treatment of amyloidogenic disease |
| 02/06/2008 | CN101116745A Human papilloma virus sample particle vaccines |
| 02/06/2008 | CN101116744A Combination neisserial compositions |
| 02/06/2008 | CN100366631C IgG Fc/HIV-gp120/C3d fusion protein |
| 02/06/2008 | CN100366293C Inhibitors of complement activation |